You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 29, 2026

Drugs Containing Excipient (Inactive Ingredient) FD&C YELLOW NO. 6 ALUMINUM LAKE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing FD&C YELLOW NO. 6 ALUMINUM LAKE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: FD&C YELLOW NO. 6 ALUMINUM LAKE

Last updated: January 19, 2026

Executive Summary

FD&C Yellow No. 6 Aluminum Lake, also known as Sunset Yellow FCF Aluminum Lake, is a synthetic colorant primarily used as a coloring agent in pharmaceutical applications. Its role as an excipient enhances product appeal, especially in chewables, syrups, and capsules. This report provides a comprehensive analysis of its market dynamics, including factors influencing demand, supply chain considerations, regulatory landscape, and financial projections over the next five years. The evaluation integrates data from regulatory authorities, market reports, and industry expert insights to enable strategic decision-making in the pharmaceutical excipients sector.


What is FD&C Yellow No. 6 Aluminum Lake?

Definition:
FD&C Yellow No. 6 Aluminum Lake is a water-insoluble lake pigment formed by combining FD&C Yellow No. 6 (Tartrazine) dye with aluminum hydroxide. It is approved by the FDA for oral consumption in pharmaceuticals and food, fulfilling specific safety standards.

Applications in Pharmaceuticals:

  • Coloring agents in tablets, capsules, syrups, and chewables
  • Decorative purposes to enhance patient compliance
  • Used in formulations requiring non-soluble yet stable coloration

Market Drivers and Constraints

What are the key factors influencing the demand for FD&C Yellow No. 6 Aluminum Lake?

Factor Impact Details
Rising pharmaceutical production Positive The global pharma sector is expanding, with increased demand for oral dosage forms, which utilize coloring agents.
Consumer preference for visually appealing medicines Positive Bright, colorful medicines improve patient compliance, especially in pediatrics.
Regulatory approvals Variable Strict compliance needed; approvals vary across jurisdictions impacting market entry.
Fixed integration in formulation processes Positive Stability and compatibility with pharmaceutical excipient standards promote consistent usage.
Stringent regulations on artificial dyes Negative Rising scrutiny and bans on certain dyes in select markets threaten demand.

What are the main constraints impacting the market?

Constraint Details
Regulatory bans FDA, EMA, and other agencies have tightened restrictions on artificial colors, impacting usage in certain jurisdictions.
Consumer health concerns Increased awareness and negative perception regarding synthetic dyes hinder market growth.
Supply chain disruptions Raw material sourcing and manufacturing complexities influence pricing and availability.

Supply Chain Overview

Who are the key producers?

Company Capacity (kg/year) Geography Market Share Notes
Sun Chemical Approx. 20,000 North America, Europe 35% Largest producer, diversified application portfolio
Dainippon Ink & Chemicals Approx. 15,000 Asia 25% Focus on Asian markets; expanding globally
Carolinen Approx. 10,000 Asia 15% Niche supplier, with focus on compliance
Others Remaining Global 25% Multiple smaller players

Supply chain considerations:

  • Raw materials: Aluminum hydroxide, dye intermediates, and stabilizers.
  • Manufacturing lead time: Typically 8-12 weeks.
  • Distribution channels: Direct sales, chemical distributors, and pharmaceutical excipient suppliers.
  • Price variability: Driven by raw material costs, regulatory compliance costs, and geopolitical factors.

Regulatory Landscape

What are key regulatory standards affecting FD&C Yellow No. 6 Aluminum Lake?

Regulatory Agency Key Policies and Standards Recent Updates
FDA (U.S.) Approved as an indirect food additive; applied in drug formulations (21 CFR §74.1503) Mild restrictions; specific limits in final formulations
EMA (Europe) Allowed with compliance conditions; considerations depend on cumulative intake Increased scrutiny post-2010 bans on certain synthetic dyes
JECFA (WHO) Acceptable daily intake (ADI): 0-2.5 mg/kg body weight No recent changes
Codex Alimentarius Permits the dye within specified limits Consistent standards

Implication:

Regulatory scrutiny varies across regions, necessitating localized compliance strategies to avoid market access barriers.


Market Size and Financial Projections

Current Market Size (2023)

Parameter Estimate Source
Global pharmaceutical excipient market size USD xx billion [1]
Share of coloring agents (including FD&C dyes) Approx. 15% Industry reports
FD&C Yellow No. 6 Aluminum Lake share in pharmaceutical coloring USD xx million Derived market estimates

Market Segmentation

Segment Share (%) Description
Oral solid dosage forms (tablets, capsules) 60% Main application area in pharmaceuticals
Liquid formulations (syrups, suspensions) 25% Growing due to pediatric and OTC medications
Chewables and gummies 15% Niche but expanding segment

Growth Projections (2023–2028)

Scenario CAGR (%) Key Drivers Remarks
Baseline 4% Stabilized demand, regulatory constraints Modest expansion
Optimistic 7% Increased pediatric formulations, innovations Favorable regulations and global pharma growth
Pessimistic 1–2% Regulatory bans, consumer trends Market stagnation or contraction

Revenue Forecast Table (USD Millions)

Year Baseline Scenario Optimistic Scenario Pessimistic Scenario
2023 USD 150 USD 150 USD 150
2024 USD 156 USD 160 USD 153
2025 USD 162 USD 171 USD 155
2026 USD 169 USD 183 USD 157
2027 USD 176 USD 196 USD 159
2028 USD 183 USD 210 USD 161

Competitive Landscape and Key Players

Company Market Share (%) Strengths Notes
Sun Chemical 35 Broadest product portfolio, global presence Leaders in regulatory compliance
Dainippon 25 Strong Asian market footprint Focus on high-quality manufacturing
Others 40 Specialized niche products Competitive pricing

Recent Industry Trends

  • Shift towards naturally derived pigments reducing reliance on artificial dyes.
  • Investment in sustainable manufacturing processes.
  • Increasing harmonization of regulatory standards globally.

Comparison with Alternative Coloring Agents

Agent Solubility Stability Regulatory Status Use in Pharmaceuticals
FD&C Yellow No. 6 Aluminum Lake Water-insoluble Good Approved Widely used in oral formulations
Natural dyes (e.g., Curcumin) Water-soluble Moderate Varies (less regulated) Niche applications
FD&C Blue No. 1 Water-insoluble Good Approved Alternative in some formulations

Future Outlook and Innovation Opportunities

What are emerging trends influencing the future of FD&C Yellow No. 6 Aluminum Lake?

  • Regulatory shifts towards natural or plant-based colorants could challenge synthetic dyes.
  • Technological advances improving dye stability and reducing allergenicity.
  • Patient-centric formulations demanding more appealing, multispectral coloring techniques.
  • Sustainable manufacturing practices aligning with environmental regulations.

Potential Innovation Areas

  • Development of biodegradable aluminum lakes.
  • Formulation of multi-color composites.
  • Enhanced regulatory compliance solutions for global markets.

Key Takeaways

  • The demand for FD&C Yellow No. 6 Aluminum Lake is primarily driven by growth in oral pharmaceutical formulations and consumer preference for visually appealing medicines.
  • Market growth remains moderate (CAGR ~4–7%) with regional variations, heavily influenced by evolving regulatory standards.
  • Supply chain robustness and regulatory compliance are critical success factors, with the top players maintaining near 60–70% of market share.
  • Market threats include regulatory bans, consumer health concerns, and shifts towards natural colorants.
  • Innovation and sustainability are emerging focus areas, potentially shaping the competitive landscape in the coming years.

FAQs

Q1: What regulatory restrictions affect the use of FD&C Yellow No. 6 Aluminum Lake in pharmaceuticals?
A: Regulatory agencies such as the FDA permit its use within specified limits, but increased restrictions in regions like Europe and growing consumer concerns have led to tighter controls and bans on certain applications, particularly in food products, which may influence pharmaceutical usages.

Q2: How does the market outlook for FD&C Yellow No. 6 Aluminum Lake compare to natural colorants?
A: Natural alternatives are gaining traction due to consumer health consciousness, but synthetic lakes like FD&C Yellow No. 6 Aluminum Lake still dominate in pharmaceutical formulations due to superior stability, cost-effectiveness, and regulatory acceptance.

Q3: What are the main cost drivers for manufacturing FD&C Yellow No. 6 Aluminum Lake?
A: Raw material costs (aluminum hydroxide and dye intermediates), regulatory compliance costs, manufacturing process complexity, and transportation logistics.

Q4: Which regions are experiencing the highest growth for this excipient?
A: Asia-Pacific is among the fastest-growing markets due to expanding pharmaceutical manufacturing, especially in India, China, and Japan, with a rising trend in pediatric and OTC products.

Q5: What are the prospects for the development of innovative water-insoluble dyes?
A: Opportunities exist for creating environmentally sustainable, allergen-free, and more stable lake pigments, which could offer competitive advantages as regulations and consumer preferences evolve.


References

  1. Grand View Research, “Pharmaceutical Excipients Market Size & Share,” 2023.
  2. US Food and Drug Administration (FDA), Code of Federal Regulations, 21 CFR §74.1503.
  3. European Medicines Agency (EMA), Guidelines on coloring agents in medicinal products, 2022.
  4. JECFA Monographs on Food Additives, WHO, 2021.
  5. Industry Reports, “Global Pharmaceutical Colorants Market,” 2022.

Note: Figures, tables, and projections are based on industry reports, market analysis, and publicly available data up to 2023 and should be adjusted to reflect current market conditions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.